Skip to main content
. 2021 Apr 12;13(8):1834. doi: 10.3390/cancers13081834

Figure 1.

Figure 1

Overall survival (OS). Comparison between patients treated with carboplatin/paclitaxel (‘CROSS’) and patients treated with 5-fluorouracil/cisplatin (‘WALSH’).